PFIZER INC Investment Income, Nonoperating
PFIZER INC (PFE) reported Investment Income, Nonoperating of $94.00 million for the 3-month period ending 2013-09-29, per its 10-Q filed 2013-11-08.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNonoperating · last filed 2013-11-08
- PFIZER INC investment income, nonoperating for the quarter ending 2013-09-29 was $94.00M, a 13.76% decline year-over-year.
- PFIZER INC investment income, nonoperating for the quarter ending 2013-06-30 was $102.00M, a 20.00% increase year-over-year.
- PFIZER INC investment income, nonoperating for the quarter ending 2013-03-31 was $95.00M, a 17.28% increase year-over-year.
- PFIZER INC investment income, nonoperating for the quarter ending 2012-12-31 was $108.00M, a 13.60% decline year-over-year.
- PFIZER INC investment income, nonoperating for fiscal 2012 was $383.00M, a 16.01% decline from fiscal 2011.
- PFIZER INC investment income, nonoperating for fiscal 2011 was $456.00M, a 14.00% increase from fiscal 2010.
- PFIZER INC investment income, nonoperating for fiscal 2010 was $400.00M, a 46.45% decline from fiscal 2009.
- PFIZER INC investment income, nonoperating for fiscal 2009 was $747.00M, a 42.00% decline from fiscal 2008.
| Period end | Investment Income, Nonoperating 3 month | Investment Income, Nonoperating 3 month as first filed | Investment Income, Nonoperating 6 month | Investment Income, Nonoperating 6 month as first filed | Investment Income, Nonoperating 9 month | Investment Income, Nonoperating 9 month as first filed | Investment Income, Nonoperating 12 month | Investment Income, Nonoperating 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2013-09-29 | $94.00M 10-Q · filed 2013-11-08 | $196.00M derived: sum of 2 quarters · filed 2013-11-08 | $291.00M 10-Q · filed 2013-11-08 | $399.00M derived: sum of 4 quarters · filed 2013-11-08 | ||||
| 2013-06-30 | $102.00M 10-Q · filed 2013-08-09 | $197.00M 10-Q · filed 2013-08-09 | $305.00M derived: sum of 3 quarters · filed 2013-08-09 | $414.00M derived: sum of 4 quarters · filed 2013-11-08 | ||||
| 2013-03-31 | $95.00M 10-Q · filed 2013-05-10 | $203.00M derived: sum of 2 quarters · filed 2013-05-10 | $312.00M derived: sum of 3 quarters · filed 2013-11-08 | $397.00M derived: sum of 4 quarters · filed 2013-11-08 | ||||
| 2012-12-31 | $108.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $217.00M derived: sum of 2 quarters · filed 2013-11-08 | $302.00M derived: sum of 3 quarters · filed 2013-11-08 | $383.00M 10-K · filed 2013-02-28 | ||||
| 2012-09-30 | $109.00M 10-Q · filed 2013-11-08 | $108.00M 10-Q · filed 2012-11-09 | $194.00M derived: sum of 2 quarters · filed 2013-11-08 | $275.00M 10-Q · filed 2013-11-08 | $400.00M derived: sum of 4 quarters · filed 2013-11-08 | |||
| 2012-07-01 | $85.00M 10-Q · filed 2013-08-09 | $86.00M 10-Q · filed 2012-08-09 | $166.00M 10-Q · filed 2013-08-09 | $167.00M 10-Q · filed 2012-08-09 | $291.00M derived: sum of 3 quarters · filed 2013-08-09 | $400.00M derived: sum of 4 quarters · filed 2013-08-09 | ||
| 2012-04-01 | $81.00M 10-Q · filed 2013-05-10 | $206.00M derived: sum of 2 quarters · filed 2013-05-10 | $315.00M derived: sum of 3 quarters · filed 2013-05-10 | $432.00M derived: sum of 4 quarters · filed 2013-05-10 | ||||
| 2011-12-31 | $125.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $234.00M derived: sum of 2 quarters · filed 2013-02-28 | $351.00M derived: sum of 3 quarters · filed 2013-02-28 | $456.00M 10-K · filed 2013-02-28 | $458.00M 10-K · filed 2012-02-28 | |||
| 2011-10-02 | $109.00M 10-Q · filed 2012-11-09 | $110.00M 10-Q · filed 2011-11-10 | $226.00M derived: sum of 2 quarters · filed 2012-11-09 | $331.00M 10-Q · filed 2012-11-09 | $332.00M 10-Q · filed 2011-11-10 | $434.00M derived: sum of 4 quarters · filed 2013-02-28 | ||
| 2011-07-03 | $117.00M 10-Q · filed 2011-08-11 | $222.00M 10-Q · filed 2012-08-09 | $325.00M derived: sum of 3 quarters · filed 2013-02-28 | $425.00M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-04-03 | $105.00M 10-Q · filed 2012-05-10 | $208.00M derived: sum of 2 quarters · filed 2013-02-28 | $308.00M derived: sum of 3 quarters · filed 2013-02-28 | $393.00M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $103.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $203.00M derived: sum of 2 quarters · filed 2013-02-28 | $288.00M derived: sum of 3 quarters · filed 2013-02-28 | $400.00M 10-K · filed 2013-02-28 | $402.00M 10-K · filed 2011-02-28 | |||
| 2010-10-03 | $100.00M 10-Q · filed 2011-11-10 | $185.00M derived: sum of 2 quarters · filed 2011-11-10 | $297.00M 10-Q · filed 2011-11-10 | $424.00M derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2010-07-04 | $85.00M 10-Q · filed 2011-08-11 | $197.00M 10-Q · filed 2011-08-11 | $324.00M derived: sum of 3 quarters · filed 2012-02-28 | $495.00M derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2010-04-04 | $112.00M 10-Q · filed 2011-05-12 | $239.00M derived: sum of 2 quarters · filed 2012-02-28 | $410.00M derived: sum of 3 quarters · filed 2012-02-28 | |||||
| 2009-12-31 | $127.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $298.00M derived: sum of 2 quarters · filed 2012-02-28 | $747.00M 10-K · filed 2012-02-28 | $746.00M 10-K · filed 2011-02-28 | ||||
| 2009-09-27 | $171.00M 10-Q · filed 2010-11-12 | $620.00M 10-Q · filed 2010-11-12 | ||||||
| 2008-12-31 | $1.29B 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |